Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Hans Peter Muhn, Berlin DE

Hans Peter Muhn, Berlin DE

Patent application numberDescriptionPublished
20080207728BICYCLIC ACYLTRYPTOPHANOLS - The present invention relates to acyltryptophanols of the general formula I,08-28-2008
200802211951,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS - The present invention relates to acyltryptophanols of the general formula I,09-11-2008
20080255117SULFONYLTRYPTOPHANOLS - The present invention relates to sulfonyltryptophanols of the general formula I,10-16-2008
200802750832,3,4,9-TETRAHYDRO-1H-CARBAZOLES - The present invention relates to 2,3,4,9-tetrahydro-1H-carbazoles of the general formula I,11-06-2008
20080287493ARYLMETHYLEN SUBSTITUTED N-ACYL-Y-AMINOALCOHOLS - The present invention relates to arylmethylen substituted N-acyl-Y-aminoalcohols of the general formula I11-20-2008
2009002995318-METHYL-19-NOR-17-PREGN-4-ENE-21,17-CARBOLACTONES, AS WELL AS PHARMACEUTICAL PREPARATIONS THAT CONTAIN THE LATTER - The invention relates to novel 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones of general formula (I), where Z=O, H01-29-2009
2009004821717Beta-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE - The 17β-cyano-19-nor-androst-4-ene derivatives of the present invention possess gestagenic activity. They have the general chemical formula 1, in which Z is selected from the group comprising O, two hydrogen atoms, NOR and NNHSO02-19-2009
2009004821817Beta-CYANO-18A-HOMO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE - The 17β-cyano-18a-homo-19-nor-androst-4-ene derivatives of the present invention possess gestagenic activity. They have the general chemical formula 1, in which Z is selected from the group comprising O, two hydrogen atoms, NOR and NNHSO02-19-2009
20090069321CYANOMETHYL SUBSTITUTED N-ACYL TRYPTAMINES - The present invention relates to cyanomethyl substituted N-acyl tryptamines of the formula I03-12-2009
20090069328ALPHA-ALKYL SUBSTITUTED N-ACYLTRYPTOPHANOLS - The present invention relates to α-alkyl substituted N-acyltryptophanols of the formula I03-12-2009
20090075987ALKYLACETYLENE SUBSTITUTED ACYLTRYPTOPHANOLS - The present invention relates to acyltryptophanols of the general formula I,03-19-2009
20090082372Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols - The present invention relates to arylmethylene substituted N-Acyl-β-amino alcohols of the formula I03-26-2009
20090099250BENZOCYCLOHEPTENE DERIVATIVES AS ESTROGENS HAVING SELECTIVE ACTIVITY - The present invention describes non-steroidal compounds of the general formula (I)04-16-2009
2010029218417BETA-CYANO-19-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE - The 17β-cyano-19-androst-4-ene derivatives of the present invention possess gestagenic activity. They have the general chemical formula 1, in which Z is selected from the group comprising O, two hydrogen atoms, NOR and NNHSO11-18-2010
2010031763217-(1'PROPENYL)-17-3'-OXIDOESTRA-4-EN-3-ONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE - The invention relates to 17-(1′-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the residues Z, R12-16-2010
2011000377915, 16-METHYLENE-17-(1'-PROPENYL)-17,3'-OXIDOESTRA-4-EN-3-ONE DERIVATIVE , USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE - The invention relates to 15,16-methylene-17-(1′-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the Z, R01-06-2011
2011001516215,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid Y-lactone derivative, use thereof and medicinal products containing the derivative - The invention relates to 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivatives with the general chemical formula I, and R01-20-2011
2011002147217-HYDROXY-19-NOR-21-CARBOXYLIC ACID-STEROID Y-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING THE DERIVATIVE - The invention relates to 17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivatives with the chemical formula I, where R01-27-2011

Patent applications by Hans Peter Muhn, Berlin DE